Status: current, Defined. Date: 31-Oct 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4212501000168116 | Dovato 50/300 (dolutegravir 50 mg + lamivudine 300 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4212511000168118 | Dovato 50/300 tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Dovato 50/300 tablet | Is a | Dovato 50/300 | true | Inferred relationship | Some | ||
| Dovato 50/300 tablet | Is a | dolutegravir 50 mg + lamivudine 300 mg tablet | true | Inferred relationship | Some | ||
| Dovato 50/300 tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Dovato 50/300 tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Dovato 50/300 tablet | has unit of use | tablet | true | Inferred relationship | Some | 2125198937 | |
| Dovato 50/300 tablet | has Australian BoSS | dolutegravir | true | Inferred relationship | Some | 1904596360 | |
| Dovato 50/300 tablet | has intended active ingredient | dolutegravir | true | Inferred relationship | Some | 1904596360 | |
| Dovato 50/300 tablet | has Australian BoSS | lamivudine | true | Inferred relationship | Some | 2125198936 | |
| Dovato 50/300 tablet | has intended active ingredient | lamivudine | true | Inferred relationship | Some | 2125198936 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Dovato 50/300 tablet, 30 | has TPUU | True | Dovato 50/300 tablet | Inferred relationship | Some | 1 |
| Dovato 50/300 tablet, 30, bottle | has TPUU | True | Dovato 50/300 tablet | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR